Prognostic evaluation of XXXX based on the pTNM classification.

@entity1 @entity2558 @entity1803 @entity121 @entity320
The prognoses of 100 consecutive @entity320 @entity1 were analyzed on the basis of @entity121 and Clark's levels as well as according to stage employing the 1987 UICC pTNM classification. Among @entity1 with lesions < or = 1.50 mm thick, the 10-year survival rate was 100% for both @entity2558 (n = 13) and pT2 (n = 6) disease, 73.4% for pT3a disease (n = 26), 62.2% for pT3b disease (n = 15), 69.3% for @entity1803 (n = 41) disease, and 38.7% for pT4 disease (n = 38). Significant differences in survival were found between the pT4 group and the @entity2558 /pT3a or @entity1803 groups. The 10-year survival rate was 100% for level II (n = 13) and level III (n = 13) disease, 58.3% for level IV (n = 46) disease, and 34.5% for level V (n = 26) disease. Significant differences were found between level V and other levels. The survival rate at 10 years was 100% for stage I (n = 18), 63.3% for stage II (n = 24), and 52.5% for stage III (n = 55). In stage IV (n = 3), there was only one @entity1 who survived for 42 months. There were significant differences in survival among all stages except I and II. The 10-year survival rate in 3 subgroups of stage III was 58.9% for pT4pN0M0 @entity1 (n = 14), 63.2% for pT,pN1M0 @entity1 (n = 31), and 20% for pT,pN2M0 @entity1 (n = 10). Significant differences were found between the pT,pN1M0 and pT,pN2M0 subgroups.(ABSTRACT TRUNCATED AT 250 WORDS)
